KLRC1 and acute lymphoblastic leukemia: For example, studies have indicated that the NK cell subsets most successful in fighting acute lymphoblastic leukaemia (ALL) expressed NKG2A, while NK cells expressing CD57 and/or KIR demonstrated greater efficacy against acute myeloid leukaemia (AML) (52).